The condition is becoming more common, it is associated with an elderly population, and, if not properly treated, it compromises the standard of living and ability to act independently of those old people, and yet the drug that is now available—despite having been approved by the Scottish Medicines Consortium—is only being prescribed on a variable ratio acr...